Variables | HICBs (n = 12) | Non-HICBs (n = 12) | p value |
---|---|---|---|
Age, years | 64.4 ± 9.6 | 65.0 ± 10.1 | 0.8857 |
Male, n (%) | 6 (50.0) | 6 (50.0) | 1.0000 |
Hemodialysis duration, years | 26.3 ± 7.9 | 20.8 ± 6.7 | 0.0785 |
Observation period, months | 61.9 ± 16.3 | 58.0 ± 12.2 | 0.5120 |
Diabetes mellitus, n (%) | 2 (16.7) | 1 (8.3) | 0.8913 |
Dry weight, kg | 51.3 ± 9.6 | 47.13 | 0.2595 |
Body mass index, kg/m2 | 20.5 ± 3.6 | 19.4 ± 2.5 | 0.7984 |
Cardiothoracic rate, % | 50.7 ± 4.9 | 51.7 ± 4.8 | 0.3092 |
Systolic blood pressure before dialysis, mmHg | 137.6 ± 25.9 | 140.4 ± 14.1 | 0.7551 |
Diastolic blood pressure before dialysis, mmHg | 74.8 ± 14.9 | 75.1 ± 10.3 | 0.9497 |
BMIPP summed score at first BMIPP SPECT | 6 (3.0–17.5) | 6 (2.0–9.5) | 0.3645 |
Hemoglobin, g/dl | 10.8 ± 0.5 | 10.6 ± 0.5 | 0.4212 |
Urea nitrogen, mg/dl | 57.8 ± 7.12 | 58.7 ± 7.5 | 0.7738 |
Creatinine, mg/dl | 9.0 ± 2.3 | 10.1 ± 2.7 | 0.3126 |
Calcium mg/dl | 8.7 ± 0.45 | 8.6 ± 0.6 | 0.7557 |
Inorganic phosphorus, mg/dl | 5.3 ± 0.8 | 5.5 ± 0.8 | 0.4139 |
Albumin, g/dl | 3.7 ± 0.3 | 3.6 ± 0.44 | 0.6687 |
β2-microglobulin, mg/l | 23.0 ± 4.6 | 29.2 ± 5.2 | 0.0056 |
C-reactive protein, mg/dl | 0.42 (0.14–0.98) | 0.58 (0.16–1.1) | 0.9310 |
Parathyroid hormone-intact, pg/ml | 88.7 (29.5–166.3) | 62.8 (16.3–139.5) | 0.3708 |
Dialysis mode (hemodialysis/hemodiafiltration), n | 12/0 | 10/2 | 0.4783 |
Dialysis time, h | 4.2 ± 0.4 | 4.6 ± 0.6 | 0.0538 |
Single pool Kt/V urea | 1.93 ± 0.27 | 2.01 ± 0.32 | 0.5016 |
Normalized protein catabolism rate, g/kg/day | 0.86 ± 0.11 | 0.89 ± 0.09 | 0.4212 |
Geriatric Nutritional Risk Index | 92.9 ± 4.2 | 90.9 ± 9.5 | 0.5092 |
Creatinine generation rate, % | 93.5 ± 20.8 | 109.0 ± 26.5 | 0.1234 |
Medications | |||
 α1 blockers, n (%) | 1 (8.3) | 2 (16.7) | 0.5371 |
 β1 blockers, n (%) | 1 (8.3) | 4 (33.3) | 0.1316 |
 Calcium channel blockers, n (%) | 6 (50.0) | 7 (58.3) | 0.6820 |
 Nitrates, n (%) | 0 (0.0) | 0 (0.0) | – |
 Angiotensin-converting enzyme inhibitors, n (%) | 1 (8.3) | 2 (16.7) | 0.5371 |
 Angiotensin II receptor blockers, n (%) | 2 (16.7) | 2 (16.7) | 1.0000 |
 Antiplatelet drugs, n (%) | 5 (41.7) | 3 (25.0) | 0.3865 |
 Stains, n (%) | 1 (8.3) | 1 (8.3) | 1.0000 |